CH680567A5 - - Google Patents

Download PDF

Info

Publication number
CH680567A5
CH680567A5 CH569/90A CH56990A CH680567A5 CH 680567 A5 CH680567 A5 CH 680567A5 CH 569/90 A CH569/90 A CH 569/90A CH 56990 A CH56990 A CH 56990A CH 680567 A5 CH680567 A5 CH 680567A5
Authority
CH
Switzerland
Prior art keywords
filling
pharmaceutical composition
ranitidine
composition according
mixture
Prior art date
Application number
CH569/90A
Other languages
English (en)
French (fr)
Inventor
Sham Kumar Chopra
Tribhovan Tarun Makadia
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of CH680567A5 publication Critical patent/CH680567A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH569/90A 1989-02-23 1990-02-22 CH680567A5 ( )

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CH680567A5 true CH680567A5 ( ) 1992-09-30

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
CH569/90A CH680567A5 ( ) 1989-02-23 1990-02-22

Country Status (26)

Country Link
US (1) US5028432A ( )
JP (1) JP2856817B2 ( )
KR (1) KR940006271B1 ( )
AT (1) AT401727B ( )
AU (1) AU629303B2 ( )
BE (1) BE1003123A3 ( )
CA (1) CA2010692C ( )
CH (1) CH680567A5 ( )
CY (1) CY1734A ( )
DE (1) DE4005650C2 ( )
DK (1) DK170209B1 ( )
FR (1) FR2643263B1 ( )
GB (2) GB8904182D0 ( )
HK (1) HK89493A ( )
HU (1) HU211930A9 ( )
IE (1) IE63179B1 ( )
IL (1) IL93490A ( )
IT (1) IT1240768B ( )
LU (1) LU87681A1 ( )
NL (1) NL193267C ( )
NZ (1) NZ232642A ( )
PH (1) PH26972A ( )
SA (1) SA90100287B1 ( )
SE (1) SE512412C2 ( )
ZA (1) ZA901348B ( )
ZW (1) ZW1790A1 ( )

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
US5635200A (en) * 1992-10-16 1997-06-03 Glaxo Group Limited Taste-making compositions of ranitidine
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ES2294197T3 (es) * 2001-12-21 2008-04-01 Supernus Pharmaceuticals, Inc. Formulacion de capsula oral con estabilidad fisica aumentada.
JP2006518380A (ja) * 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション 固体分散体組成物
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
EP2585025B2 (en) 2010-06-23 2022-10-26 Colgate-Palmolive Company Therapeutic oral composition
CA2820425A1 (en) 2010-12-20 2012-06-28 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
MX347065B (es) 2010-12-20 2017-04-11 Colgate Palmolive Co Composicion de cuidado oral encapsulada con gelatina que contiene activos de oclusion dental, modificador hidrofobico de viscosidad y portador de aceite.
MY163496A (en) 2010-12-20 2017-09-15 Colgate Palmolive Co Non-aqueous oral care composition containing dental occlusion actives
WO2018083583A1 (en) * 2016-11-01 2018-05-11 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
KR890001179B1 (ko) * 1983-08-01 1989-04-26 알.피.쉐레르 코오포레이션 지속적으로 방출되는 복용체
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
FR2636532B1 (fr) * 1988-09-20 1993-11-19 Glaxo Group Ltd Compositions pharmaceutiques

Also Published As

Publication number Publication date
DK48090A (da) 1990-08-24
ZW1790A1 (en) 1991-10-16
GB8904182D0 (en) 1989-04-05
LU87681A1 (fr) 1991-10-08
CY1734A (en) 1994-05-06
IL93490A0 (en) 1990-11-29
SE512412C2 (sv) 2000-03-13
AU5007390A (en) 1990-08-30
NL193267B (nl) 1999-01-04
DK48090D0 (da) 1990-02-22
JPH03200728A (ja) 1991-09-02
CA2010692A1 (en) 1990-08-23
FR2643263A1 (fr) 1990-08-24
IT9047659A0 (it) 1990-02-22
IE900651L (en) 1990-08-23
AT401727B (de) 1996-11-25
BE1003123A3 (fr) 1991-12-03
JP2856817B2 (ja) 1999-02-10
CA2010692C (en) 1995-12-12
US5028432A (en) 1991-07-02
SE9000625D0 (sv) 1990-02-22
HU211930A9 (en) 1996-01-29
GB2229094A (en) 1990-09-19
PH26972A (en) 1992-12-28
NZ232642A (en) 1992-07-28
IL93490A (en) 1994-07-31
NL193267C (nl) 1999-05-06
IT9047659A1 (it) 1991-08-22
KR940006271B1 (ko) 1994-07-14
GB9004016D0 (en) 1990-04-18
DE4005650C2 (de) 1999-03-25
SE9000625L (sv) 1990-08-24
GB2229094B (en) 1993-01-06
ATA42190A (de) 1996-04-15
ZA901348B (en) 1991-03-27
DE4005650A1 (de) 1990-09-06
AU629303B2 (en) 1992-10-01
NL9000428A (nl) 1990-09-17
HK89493A (en) 1993-09-03
SA90100287B1 (ar) 1999-08-15
DK170209B1 (da) 1995-06-19
IT1240768B (it) 1993-12-17
IE63179B1 (en) 1995-03-22
FR2643263B1 (fr) 1994-09-16
KR900012612A (ko) 1990-09-01

Similar Documents

Publication Publication Date Title
CH680567A5 ( )
WO1998043635A1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino- 3-pyrazolecarboxamide, de ses sels et de leurs solvates
CA2231342C (fr) Composition pharmaceutique pour administration par voie orale
FR2737121A1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
NZ539046A (en) Chemotherapeutic self-emulsifying microemulsion compositions of paclitaxel with improved oral bioavailability
CA2470443A1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
FR2753376A1 (fr) Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
EP2637645B1 (fr) Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
EP1165042B1 (fr) Suspension pharmaceutique buvable d'ibuprofene
EP0523153B1 (fr) Gelule huileuse de ketoprofene
WO1997021440A1 (en) A solution for oral administration containing ici 182,780
EP0356325B1 (fr) Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glycéride gélifié par au moins un polymère cellulosique
EP0265338B1 (fr) Compositions thérapeutiques stables à base d'huile végétale hydrophobe et son procédé de préparation
WO2000059468A1 (fr) Suspension pharmaceutique buvable
CA2319609C (en) Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
FR2809958A1 (fr) Composition pharmaceutique sous forme liquide destinee a l'administration par voie orale d'un principe actif, ayant un gout desagreable, notamment un gout amer

Legal Events

Date Code Title Description
PL Patent ceased